Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Depression
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Depression
    Lower Childhood IQ Associated With Higher Risk of Adult Mental Disorders - (DGNews)
    Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease - (JAMA)
    TopAbstracts in Depression 11/26/2008 - (DGNews)
    Change in Health Behaviours May Link Depression and Cardiovascular Events - (DGNews)
    Fluoxetine, Paroxetine Associated With Increased Risk of Foetal Heart Anomalies - (DGNews)

    News archive

     Recent webcasts/CME - Depression

    Webcasts/CME archive

     Recent cases - Depression
      Sexual Dysfunction in a Young Mother
      Psychiatric Disorder Associated with Vacuum-Assisted Breast Biopsy Clip Placement: A Case Report
      A Postmenopausal Woman Presenting with Ekbom Syndrome Associated with Recurrent Depressive Disorder: A Case Report
      Affective Psychosis, Hashimoto's Thyroiditis, and Brain Perfusion Abnormalities: Case Report
      Dissecting the Determinants of Depressive Disorders Outcome: An in Depth Analysis of Two Clinical Cases

      Cases archive
        




      my personal edition > depression > news
      divider

        E-Mail this DGDispatch to a colleague

      DGDispatch


      Levetiracetam Appears Useful in Women and Children With Bipolar Disease: Presented at APA

      By Ed Susman

      NEW YORK, NY -- May 10, 2004 -- The antiepileptic agent levetiracetam may be useful in treating patients with bipolar disorders who, despite standard regimens, still have symptoms of the disorder, researchers said here May 4th at the American Psychiatric Association 157th Annual Meeting.

      "Levetiracetam was generally well tolerated and no adverse events were reported," said Ali Ahmadi, MD, Department of Psychiatry, Medical Center of Central Georgia, Macon, Georgia. The addition of levetiracetam improves symptoms such as mood instability, irritability, impulsivity, poor sleep and racing thoughts, he said.

      Over the past decade several of the newer antiepileptic drugs -- such as levetiracetam and topiramate -- have been tested extensively in other areas of neurology and psychiatry. Dr. Ahmadi said levetiracetam's safety profile and mechanisms of actions have led to its use in bipolar disorder patients.

      He reviewed charts of 30 patients -- 18 women and 12 men -- who ranged in age from 5 to 50 years. Eight of the nine children treated were boys. None of the girls in the study -- which included three adolescents -- were under the age of 12 years.

      Dr. Ahmadi said that 19 patients appeared to show good or excellent response to treatment with levetiracetam. The children (ages 5-12) scored 3.8 on a scale of 0-4, where 4 represented an excellent response. Adolescents scored 2.4 and adults 3.0.

      "Results of this chart review suggest that levetiracetam may be effective in improving selected symptoms of bipolar disorder when added to existing therapy," Dr. Amahdi said during his poster presentation. "Additional studies are needed to evaluate the effects of levetiracetam for the treatment of patients with bipolar disorder."

      The investigator-initiated study received financial support from UCB Pharma, the company that developed levetiracetam.


      [Presentation title: "Levetiracetam as an add-on in adults and children with bipolar disorder." Abstract #NR404]



      E-Mail this DGDispatch to a colleague   To print, use this version






      All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send